Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer

被引:28
作者
Kang, Hyeon-Gu [1 ,2 ,3 ]
Kim, Won-Jin [1 ,2 ,3 ]
Kang, Hyeok-Gu [4 ,5 ]
Chun, Kyung-Hee [4 ,5 ]
Kim, Seok-Jun [1 ,2 ,3 ]
机构
[1] Chosun Univ, Coll Nat Sci, Dept Biomed Sci, Gwangju 61452, South Korea
[2] Chosun Univ, Dept Life Sci, Gwangju, South Korea
[3] Chosun Univ, Brain Korea 21 Plus Res Team Bioact Control Techn, Gwangju, South Korea
[4] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[5] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
TARGETED THERAPY; METASTASIS; CELLS; RHAMM;
D O I
10.1158/1541-7786.MCR-19-0811
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The hyaluronan-mediated motility receptor (HMMR) is over-expressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing to lack of detailed studies on gastric tumorigenesis. Therefore, we elucidated the functional and regulatory mechanisms of HMMR in gastric cancer. Using publicly available data, we confirmed HMMR overexpression in patients with gastric cancer. HMMR silencing decreased proliferation, migration, and invasion of gastric cancer cells, whereas HMMR overexpression reversed these effects. A gastric cancer xenograft mouse model showed statistically significant inhibition of tumor growth upon HMMR depletion. Previous data from cDNA microarray showed reduced HMMR expression upon inhibition of galectin-3. However, overexpression of galectin-3 increased HMMR expression, cell proliferation, and motility in gastric cancer cells, whereas HMMR silencing blocked these effects. Interestingly, galectin-3 interacted directly with C/EBP beta and bound to HMMR promoter to drive its transcription, and gastric cancer cell proliferation and motility. Altogether, high expression of HMMR promoted gastric cancer cell proliferation and motility and could be a prognostic factor in gastric cancer. In addition, HMMR expression was regulated by the interaction between C/EBP beta and galectin-3. Therefore, targeting HMMR along with galectin-3 and C/EBPb complex could be a potential treatment strategy for inhibiting gastric cancer progression and metastasis.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 41 条
[1]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[2]   Adjuvant therapy for locally advanced gastric cancer [J].
Aoyama, Toru ;
Yoshikawa, Takaki .
SURGERY TODAY, 2017, 47 (11) :1295-1302
[3]   Galectin-3 Activates PPARγ and Supports White Adipose Tissue Formation and High-Fat Diet-Induced Obesity [J].
Baek, Jung-Hwan ;
Kim, Seok-Jun ;
Kang, Hyeok Gu ;
Lee, Hyun-Woo ;
Kim, Jung-Hoon ;
Hwang, Kyung-A ;
Song, Jaewhan ;
Chun, Kyung-Hee .
ENDOCRINOLOGY, 2015, 156 (01) :147-156
[4]   Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis [J].
Bahrami, S. B. ;
Tolg, C. ;
Peart, T. ;
Symonette, C. ;
Veiseh, M. ;
Umoh, J. U. ;
Holdsworth, D. W. ;
McCarthy, J. B. ;
Luyt, L. G. ;
Bissell, M. J. ;
Yazdani, A. ;
Turley, E. A. .
INTEGRATIVE BIOLOGY, 2017, 9 (03) :223-237
[5]   Increased RHAMM expression relates to ovarian cancer progression [J].
Buttermore, Stephanie T. ;
Hoffman, Mitchel S. ;
Kumar, Ambuj ;
Champeaux, Anne ;
Nicosia, Santo V. ;
Kruk, Patricia A. .
JOURNAL OF OVARIAN RESEARCH, 2017, 10
[6]   RHAMM mRNA expression in proliferating and migrating cells of the developing central nervous system [J].
Casini, P. ;
Nardi, I. ;
Ori, M. .
GENE EXPRESSION PATTERNS, 2010, 10 (2-3) :93-97
[7]   Gastric cancer [J].
Catalano, Vincenzo ;
Labianca, Roberto ;
Beretta, Giordano D. ;
Gatta, Gemma ;
De Braud, Filippo ;
Van Cutsem, Eric .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (02) :127-164
[8]   Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents [J].
Cheong, Teak-Chin ;
Shin, Ji-Young ;
Chun, Kyung-Hee .
CANCER SCIENCE, 2010, 101 (01) :94-102
[9]   HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development [J].
Connell, Marisa ;
Chen, Helen ;
Jiang, Jihong ;
Kuan, Chia-Wei ;
Fotovati, Abbas ;
Chu, Tony L. H. ;
He, Zhengcheng ;
Lengyell, Tess C. ;
Li, Huaibiao ;
Kroll, Torsten ;
Li, Amanda M. ;
Goldowitz, Daniel ;
Frappart, Lucien ;
Ploubidou, Aspasia ;
Patel, Milian S. ;
Pilarski, Linda M. ;
Simpson, Elizabeth M. ;
Lange, Philipp F. ;
Allan, Douglas W. ;
Maxwell, Christopher A. .
ELIFE, 2017, 6
[10]   Galectin-3:: An open-ended story [J].
Dumic, J ;
Dabelic, S ;
Flögel, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (04) :616-635